Back to mobile site

UBS Reiterates Buy Rating on Abbott Labs (ABT) on EPD Strength

October 19, 2026 9:33 AM EDT Send to a Friend
UBS analyst Patrick Wood reiterated a Buy rating and $125.00 price target on Abbott Labs (NYSE: ABT).The analyst commented, "EPD ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login